Research on ulcerative colitis is exploring various aspects of the disease, including signaling pathways and therapeutic targets. Studies are investigating potential treatments, such as probiotics, mesalamine-NSAID hybrids, and natural products, as well as the role of different cells, including neutrophils and macrophages, in the disease. The relationship between ulcerative colitis and colorectal cancer is also being examined, with a focus on mechanisms, surveillance, and prevention.